Michio Kanekiyo

Lecanemab in Early Alzheimer’s Disease

Christopher H. van Dyck, Chad J. Swanson, Paul Aisen et al. · New England Journal of Medicine · 2022 · 4.7K citations · Full text

Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study

Eric McDade, Jeffrey L. Cummings, Shobha Dhadda et al. · Alzheimer s Research & Therapy · 2022 · 260 citations · Full text

Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive Impairment

Yan Hu, Kristopher M. Kirmess, Matthew R. Meyer et al. · JAMA Network Open · 2022 · 125 citations · Full text

Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease

Lawrence S. Honig, Marwan N. Sabbagh, Christopher H. van Dyck et al. · Alzheimer s Research & Therapy · 2024 · 121 citations · Full text

ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease

Lawrence S. Honig, Jerome Barakos, Shobha Dhadda et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2023 · 101 citations · Full text